Live Update
From the Liveblog of
Monday, February 8, 2021
Israeli firm begins 2nd trial of coronavirus antibody drug
An Israeli company has begun its second trial of a coronavirus antibody drug, after a promising first trial.
The drug, manufactured from antibodies found in the plasma of recovered coronavirus patients and produced by the Kamada pharmaceutical firm, has been administered to 70 patients, according to Zman Yisrael, the Times of Israel’s sister site.
If you’d like to comment, join
The Times of Israel Community.
The Times of Israel Community.
JOIN THE TOI COMMUNITY
Already a member? Log in here







